Kattumantham (constipation)in children-Poduthalai Kudineer (internal)

Clinical evaluation of poduthalai Kudineer (A Siddha Drug)in the treatment of kattumantham (constipation)in children.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013492

Enrollment

Registered

2018-04-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Kattumantham(constipation)

Interventions

Intervention1: Poduthalai kudineer: 10-20 ml will be given orally twice a day for a period of 3 days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: constipation indigestion stomach pain fever cough yawning flatulance irritation lethargy not feeding well

Exclusion criteria

Exclusion criteria: high temp >102 degree F intolerable stomach pain systemic diseases and disorder

Design outcomes

Primary

Measure	Time frame
Vesikari scoring systemTimepoint: 3 days	—

Secondary

Measure	Time frame
Reduction in the recurrence of the disease and improvement in the quality of life of childrenTimepoint: 3 days	—

Countries

India

Contacts

Public ContactDr R Rajalakshmi

National institute of siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026